[ Pharmaceutical Sciences Asia - ONLINE ]
E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

DOI: 10.29090/psa.2023.03.22.333Pharm Sci Asia 2023; 50(3), 211-219
 

Anti-neuroinflammatory mechanism of safinamide in inhibiting lipopolysaccharide-induced microglial activation

Jashann Ashwyn1, Yong Qi Leong2, Brianna1, Khuen Yen Ng2, Soi Moi Chye1, Anna Pick Kiong Ling1, Kenny Gah Leong Voon3, Yin Yin Ooi4, Yee Lian Tiong5, Rhun Yian Koh1*

1 International Medical University, No. 126, Jalan Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur, Malaysia
2 Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya, Selangor, Malaysia
3 University of Nottingham Malaysia, Jalan Broga, Semenyih, Selangor, Malaysia
4 Taylors University, 1, Jalan Taylors, Subang Jaya, Selangor, Malaysia
5 UCSI University, No. 1, UCSI Heights, Jalan Puncak Menara Gading, Taman Connaught, Cheras, Wilayah Persekutuan Kuala Lumpur, Malaysia


Neuroinflammation is an inflammatory response in the central nervous system that may lead to neurodegenerative diseases, such as Parkinson's disease (PD). PD is the second most common neurodegenerative disorder with a high prevalence among elderly individuals. Microglia, which are associated with neuroprotection, are activated during inflammation, resulting in damage to dopaminergic neurons in the substantia nigra. Based on previous studies, safinamide can provide neuroprotection to dopaminergic neurons by inhibiting microglial activation. Hence, this study aims to investigate the anti-neuroinflammatory mechanism of safinamide in inhibiting lipopolysaccharide (LPS)-induced microglial activation. 2,5-diphenyl-2H-tetrazolium bromide (MTT) assay was used to evaluate the cytotoxicity of safinamide on BV-2 (microglial) cells. Maximum non-toxic dose (MNTD) and half MNTD of safinamide were then calculated. To determine whether safinamide could rescue lipopoly-saccharide-treated BV-2 cells from cell death and oxidative stress, MTT assay and dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay were performed, respectively. Enzyme-linked immunosorbent assay (ELISA) was performed to investigate the involvement of STAT1/NF-kappa B pathway proteins in the activation of microglia. The MNTD of safinamide was determined to be 29.5±10.66 μM. Safinamide was not able to rescue BV-2 cells from LPS-induced cell death. Nevertheless, a slight reduction of reactive oxygen species levels was noted when LPS-induced BV-2 cells were treated with safinamide. There was a slight decrease in protein expression of STAT1, NF-kappa B, iNOS and COX-2 in the LPS-induced BV-2 cells after treatment with safinamide. While safinamide did not rescue BV-2 cells from cell death, safinamide has been shown to slightly reduce oxidative stress in BV-2 cells.


Keyword:

Safinamide, Anti-inflammation, Microglial cells, STAT1/NF-kappa B pathway, Oxidative stress




Download full paper (PDF File size: 560.36 KB.)





Vol.50
No.3
July-September 2023

See other volume

 


Vol.50
No.2
April-June 2023

See other volume

 


Vol.50
No.1
January-March 2023

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University



Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0

    Copyright © 2017-2023
    Faculty of Pharmacy, Mahidol University, THAILAND
 

We use Cookies

This site uses cookies to personalise your experience and analyse site traffic. By Clicking ACCEPT or continuing to browse the site you are agreeing to our use of cookies.